Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911–20. https://doi.org/10.1056/NEJMoa1307361.
Article CAS PubMed PubMed Central Google Scholar
Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921–31. https://doi.org/10.1056/NEJMoa1307362.
Article CAS PubMed Google Scholar
Riazi MA, Brinkman-Mills P, Nguyen T, Pan H, Phan S, Ying F, et al. The human homolog of insect-derived growth factor, CECR1, is a candidate gene for features of cat eye syndrome. Genomics. 2000;64(3):277–85. https://doi.org/10.1006/geno.1999.6099.
Article CAS PubMed Google Scholar
Hashem H, Kelly SJ, Ganson NJ, Hershfield MS. Deficiency of adenosine deaminase 2 (DADA2), an inherited cause of polyarteritis nodosa and a mimic of other systemic rheumatologic disorders. Curr Rheumatol Rep. 2017;19(11):70. https://doi.org/10.1007/s11926-017-0699-8.
Article CAS PubMed Google Scholar
Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, et al. Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol. 2016;36(3):179–86. https://doi.org/10.1007/s10875-016-0245-x.
Article CAS PubMed Google Scholar
Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39(5):e293–6. https://doi.org/10.1097/MPH.0000000000000805.
Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, et al. Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol. 2018;9:1361. https://doi.org/10.3389/fimmu.2018.01361.
Article CAS PubMed PubMed Central Google Scholar
Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648–56. https://doi.org/10.1136/annrheumdis-2016-210802.
Article CAS PubMed Google Scholar
Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020;145(6):1664-72 e10. https://doi.org/10.1016/j.jaci.2019.12.908.
Article CAS PubMed PubMed Central Google Scholar
Ozen S, Batu ED, Taskiran EZ, Ozkara HA, Unal S, Guleray N, et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2. J Rheumatol. 2020;47(1):117–25. https://doi.org/10.3899/jrheum.181384.
Article CAS PubMed Google Scholar
Kendall JL, Springer JM. The many faces of a monogenic autoinflammatory disease: adenosine deaminase 2 deficiency. Curr Rheumatol Rep. 2020;22(10):64. https://doi.org/10.1007/s11926-020-00944-1.
Article CAS PubMed PubMed Central Google Scholar
Sharma A, Naidu G, Sharma V, Jha S, Dhooria A, Dhir V, et al. Deficiency of adenosine deaminase 2 in adults and children: experience from India. Arthritis Rheumatol. 2021;73(2):276–85. https://doi.org/10.1002/art.41500.
Article CAS PubMed Google Scholar
Lee PY, Aksentijevich I, Zhou Q. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2). Semin Immunopathol. 2022;44(3):269–80. https://doi.org/10.1007/s00281-022-00918-8.
Article CAS PubMed Google Scholar
Michniacki TF, Hannibal M, Ross CW, Frame DG, DuVall AS, Khoriaty R, et al. Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure. J Clin Immunol. 2018;38(2):166–73. https://doi.org/10.1007/s10875-018-0480-4.
Article CAS PubMed Google Scholar
Ghurye RR, Sundaram K, Smith F, Clark B, Simpson MA, Fairbanks L, et al. Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2). Br J Haematol. 2019;186(3):e60–4. https://doi.org/10.1111/bjh.15896.
Albalawi R, Hanafy E, Alnafea H, Altowijiry M, Riyad S, Abufara F, et al. Novel adenosine deaminase 2 (ADA2) mutations associated with hematological manifestations. J Investig Med High Impact Case Rep. 2021;9:23247096211056770. https://doi.org/10.1177/23247096211056770.
Article PubMed PubMed Central Google Scholar
Ferriani MPL, Valera ET, de Sousa GR, Sandrin-Garcia P, de Moura RR, Hershfield MS, et al. ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype. Rheumatology (Oxford). 2021;60(7):e237–9. https://doi.org/10.1093/rheumatology/keab011.
Hashem H, Bucciol G, Ozen S, Unal S, Bozkaya IO, Akarsu N, et al. Hematopoietic cell transplantation cures adenosine deaminase 2 deficiency: report on 30 patients. J Clin Immunol. 2021;41(7):1633–47. https://doi.org/10.1007/s10875-021-01098-0.
Article CAS PubMed PubMed Central Google Scholar
PoswarFde O, da Fonseca RM, de Albuquerque LC, Zhou Q, Jardim LB, Monte TL, et al. Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis. J Neurol. 2016;263(4):818–20. https://doi.org/10.1007/s00415-016-8070-y.
Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open. 2016;2(1):e000236. https://doi.org/10.1136/rmdopen-2015-000236.
Article CAS PubMed PubMed Central Google Scholar
Moens L, Hershfield M, Arts K, Aksentijevich I, Meyts I. Human adenosine deaminase 2 deficiency: a multi-faceted inborn error of immunity. Immunol Rev. 2019;287(1):62–72. https://doi.org/10.1111/imr.12722.
Article CAS PubMed Google Scholar
Bulut E, Erden A, Karadag O, Oguz KK, Ozen S. Deficiency of adenosine deaminase 2; special focus on central nervous system imaging. J Neuroradiol. 2019;46(3):193–8. https://doi.org/10.1016/j.neurad.2018.05.002.
Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, et al. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int. 2018;38(1):129–36. https://doi.org/10.1007/s00296-017-3740-3.
Article CAS PubMed Google Scholar
Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88(2):279–90. https://doi.org/10.1189/jlb.1109764.
Article CAS PubMed Google Scholar
Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci. 2017;74(3):555–70. https://doi.org/10.1007/s00018-016-2357-0.
Article CAS PubMed Google Scholar
Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38(5):569–78. https://doi.org/10.1007/s10875-018-0525-8.
Article CAS PubMed PubMed Central Google Scholar
Pinto B, Deo P, Sharma S, Syal A, Sharma A. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment. Clin Rheumatol. 2021;40(10):3883–96. https://doi.org/10.1007/s10067-021-05711-w.
Lee PY. Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2. Front Pediatr. 2018;6:282. https://doi.org/10.3389/fped.2018.00282.
Article PubMed PubMed Central Google Scholar
Grossi A, Cusano R, Rusmini M, Penco F, Schena F, Podda RA, et al. ADA2 deficiency due to a novel structural variation in 22q11.1. Clin Genet. 2019;95(6):732–3. https://doi.org/10.1111/cge.13518.
Article CAS PubMed Google Scholar
Li GM, Cao Q, Shen Q, Sun L, Zhai YH, Liu HM, et al. Gene mutation analysis in 12 Chinese children with congenital nephrotic syndrome. BMC Nephrol. 2018;19(1):382. https://doi.org/10.1186/s12882-018-1184-y.
Article CAS PubMed PubMed Central Google Scholar
Wang W, Zhang T, Zheng W, Zhong L, Wang L, Li J, et al. Diagnosis and management of adenosine deaminase 2 deficiency children: the experience from China. Pediatr Rheumatol Online J. 2021;19(1):44. https://doi.org/10.1186/s12969-021-00535-z.
Article PubMed PubMed Central Google Scholar
Liu L, Wang W, Wang Y, Hou J, Ying W, Hui X, et al. A Chinese DADA2 patient: report of two novel mutations and successful HSCT. Immunogenetics. 2019;71(4):299–305. https://doi.org/10.1007/s00251-018-01101-w.
Article CAS PubMed Google Scholar
Deuitch NT, Yang D, Lee PY, Yu X, Moura NS, Schnappauf O, et al. TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2). J Allergy Clin Immunol. 2022;149(5):1812-6 e6. https://doi.org/10.1016/j.jaci.2021.10.030.
Article CAS PubMed Google Scholar
Guo L, Wang J, Yang X, Zheng R, Deuitch N, Tao P, et al. Novel ADA2 compound heterozygous mutations resulting in deficiency of adenosine deaminase 2 in a pair of siblings. J Clin Immunol. 2021;41(4):837–42. https://doi.org/10.1007/s10875-021-00981-0.
留言 (0)